Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/1129
Title: Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer's disease from healthy controls
Authors: Ozbek, Yagmur
Fide, Ezgi
Yener, Görsev
Keywords: Resting-state EEG
Early-onset AD
Late-onset AD
FFT
Alpha/theta ratio
Power
Mild Cognitive Impairment
Cerebrospinal-Fluid Biomarkers
Subjective Memory Complaints
Functional Connectivity
Quantitative Eeg
Hippocampal Atrophy
Alpha-Rhythms
Gray-Matter
Metabolic Function
Band Oscillations
Publisher: Elsevier Ireland Ltd
Abstract: Objectives: The present study aims to compare early-onset Alzheimer's disease (EOAD) patients with healthy controls (HC), and late-onset Alzheimer's disease (LOAD) patients using resting-state delta, theta, alpha, and beta oscillations and provide a cut-off score of alpha/theta ratio to discriminate individuals with EOAD and young HC. Methods: Forty-seven individuals with EOAD, 51 individuals with LOAD, and demographically-matched 49 young and 51 older controls were included in the study. Spectral-power analysis using Fast-Fourier Transformation (FFT) is performed on resting-state electroencephalography (EEG) data. Delta, theta, alpha, and beta oscillations compared between groups and Receiver Operating Characteristic (ROC) curve analysis was conducted. Results: Compared to healthy controls individuals with EOAD showed an increase in slow frequency bands and a decrease in fast frequency bands. Frontal alpha/theta power ratio is the best discriminating value between EOAD and young HC with the sensitivity and specificity greater than 80% with area under the curve (AUC) 0.881. Conclusions: EOAD display more widespread and severe electrophysiological abnormalities than LOAD and HC which may reflect more pronounced pathological burden and cholinergic deficits in EOAD. Additionally, the alpha/theta ratio can discriminate EOAD and young HC successfully. Significance: This study is the first to report that resting-state EEG power can be a promising marker for diagnostic accuracy between EOAD and healthy controls. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
URI: https://doi.org/10.1016/j.clinph.2021.05.012
https://hdl.handle.net/20.500.14365/1129
ISSN: 1388-2457
1872-8952
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
143.pdf
  Restricted Access
1.24 MBAdobe PDFView/Open    Request a copy
Show full item record



CORE Recommender

WEB OF SCIENCETM
Citations

19
checked on Jul 3, 2024

Page view(s)

56
checked on Jul 1, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.